Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound shows superior efficacy in glucose control and weight management compared to single agonists.
The molecular structure of Tirzepatide features PEG modification on the lys side chain, enhancing water solubility while maintaining biological activity. Clinical studies demonstrate significant weight reduction potential, with trial participants showing 15-20.9% body weight loss over 72 weeks at different dosages.
As a research chemical, Tirzepatide offers scientists valuable insights into metabolic regulation mechanisms. The compound's dual agonist activity at both GIP and GLP-1 receptors creates unique pharmacological effects distinct from single-pathway medications.
Proper storage is essential for maintaining peptide integrity. Store Tirzepatide in a cool, dry environment protected from light and moisture. Avoid repeated freeze-thaw cycles and prolonged exposure to air or solution.
This product is supplied as white lyophilized powder in sterile vials with rubber stoppers. Each vial contains precisely measured 10mg of active compound for accurate dosing in research applications.
For researchers looking to buy tirzepatide compound UK, we offer pharmaceutical grade material with comprehensive analytical documentation including HPLC purity reports and mass spectrometry verification.
The development of Tirzepatide represents an important advancement in metabolic research, combining the effects of two incretin hormones into a single molecule. This innovative approach may lead to new therapeutic strategies for metabolic disorders.
When handling Tirzepatide for research purposes, follow standard laboratory safety protocols including appropriate personal protective equipment. The compound should only be used by qualified researchers in controlled settings.
